Sun Yuyun, Cai Xin, Wang Zheng, Sun Yun, Cheng Jingyi
Clin Nucl Med. 2024 Jan 1;49(1):e25-e27. doi: 10.1097/RLU.0000000000004965. Epub 2023 Nov 24.
A 67-year-old woman who was diagnosed with intrahepatic cholangiocellular carcinoma (CCC) by biopsy underwent 18 F-FDG and 18 F-AIF-FAPI-04 PET/CT for initial and treatment assessment. In addition to CCC, she had a history of hepatic hemangioma for 3 years. 18 F-FDG PET/CT images showed increased uptake in CCC, but no uptake in hemangiomas. However, images on 18 F-AIF-FAPI-04 PET/CT indicated negative 18 F-AIF-FAPI-04 uptake in CCC, but intense activity in hemangiomas. Our case illustrates that hepatic hemangioma demonstrated intense 18 F-AIF-FAPI-04 uptake, and final diagnosis should be made with caution.
一名67岁女性经活检确诊为肝内胆管细胞癌(CCC),接受了18F-FDG和18F-AIF-FAPI-04 PET/CT检查以进行初始评估和治疗评估。除CCC外,她有3年肝血管瘤病史。18F-FDG PET/CT图像显示CCC摄取增加,但血管瘤无摄取。然而,18F-AIF-FAPI-04 PET/CT图像显示CCC对18F-AIF-FAPI-04摄取为阴性,但血管瘤有强烈活性。我们的病例表明肝血管瘤表现出强烈的18F-AIF-FAPI-04摄取,最终诊断应谨慎做出。